The CRBN gene helps cells decide when certain proteins should be broken down, which supports normal brain development and growth. If this gene does not work well, some people may have developmental delay, learning difficulties, or seizures, depending on the variant. In medicine, this gene is important because it is the main cell target of thalidomide and related drugs. That link made CRBN better known after scientists connected it to thalidomide’s effects, including changes in limb development in babies exposed during pregnancy.
What is a gene?
A gene is a section of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the directions for producing proteins, the working parts of cells. Other genes mainly determine when certain processes happen, where they happen, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in greater depth, you can read more in the LearnHub.
Overview
CRBNGene function
What if the gene works
The CRBN gene helps cells control when certain proteins are broken down. This helps support normal cell growth, brain function, and development.
Risk
What if the gene does not work
More disruptive variants in the CRBN gene can cause an inherited condition with intellectual disability, delayed development, and sometimes seizures. Milder variants may lead to a less marked pattern.
Treatment
What does that mean for your treatment
No CRBN-specific treatment or management approach is currently established for people with pathogenic variants in the CRBN gene. CRBN is well known in cancer research because it is the cellular target of thalidomide, lenalidomide, and pomalidomide, and tumor CRBN levels or variants may influence response or resistance in some blood cancers.
Conditions associated with CRBN
Gene function
What if the gene works
Inside your cells, the CRBN gene helps manage which proteins stay in use and which are cleared away. Its protein works as part of a larger protein-labeling system that keeps cell activity balanced. In everyday terms, the CRBN gene helps control protein breakdown in your cells.
The CRBN gene helps cells recognize certain proteins that should be marked for removal. It acts as a selector within a larger protein-labeling system, so the right proteins are chosen at the right time.
After selected proteins are tagged, the cell can break them down and replace them as needed. This normal turnover helps keep cell signals and routine cell activity in balance.
By controlling which proteins are cleared, the CRBN gene supports orderly growth and steady communication inside cells. This helps many tissues maintain normal day to day function.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help make up normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change the function of a gene more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CRBN gene can change the cereblon protein’s shape, stability, or binding to partner proteins, which may weaken the cell system that tags selected proteins for removal. This is how CRBN gene variants affect protein function: milder changes may leave some activity, while more severe variants can result in little or no working protein. When the functional loss is greater, associated developmental features may appear earlier or be more pronounced.
How variants are linked to conditions
Pathogenic variants in the CRBN gene can cause a rare inherited form of intellectual disability, often with developmental delay and sometimes seizures or behavior changes. Among the conditions linked to CRBN gene variants, the main well-established one is autosomal recessive intellectual developmental disability, which usually appears when a person inherits a disease causing variant in both copies of the gene. A confirmed harmful variant in both CRBN gene copies can help establish the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely present in the general population. Most do not have a direct effect on health and simply add to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-studied variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CRBN gene. For many living with a CRBN gene change, risk depends mainly on the exact variant and family pattern, so personal guidance from a doctor or genetic counselor can be helpful.
Inheritance of CRBN variants
For families asking about CRBN gene inheritance, the best-established pattern is autosomal recessive. This means a child usually inherits one CRBN variant from each parent, and the parents are often healthy carriers who each have one changed copy of the CRBN gene. When both parents carry a variant, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child who inherits neither variant.
What does my CRBN result mean for my family?
For the recognized condition linked to the CRBN gene, the family pattern is usually recessive. This means parents of an affected child are often healthy carriers, and brothers or sisters may also be carriers or, less often, have the condition. Other relatives on both sides of the family may carry the same gene change, so the result can matter beyond one person.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the CRBN gene, CRBN genetic testing uses a blood or saliva sample to read the gene's DNA and look for sequence changes. Results may show a benign variant, a variant linked to a genetic condition, or a variant of uncertain significance, meaning the result is not yet clear.
When should I consider getting a genetic test?
There is not yet a broadly established, CRBN-specific medical reason for testing. It may be included in a broader genetic test when someone has unexplained developmental delay, learning problems, or seizures, especially if similar features run in the family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. Over time, factors like lifestyle, environment, age, and medical history also influence how the body functions. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly, while others are more or less sensitive to its effects. This helps explain why the same treatment may work well for one person but cause fewer benefits or more side effects in another. These differences are common and are one part of why medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way a person responds to medications. It studies gene drug relationships to help explain why the same treatment may work differently in different people. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed, more personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the CRBN gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so concerns about side effects, treatment response, or changes to your medicines are best discussed with your doctor. CRBN has been studied in people treated with thalidomide-like cancer medicines, especially for some blood cancers, but this is not a routine part of everyday prescribing.
History
The CRBN gene entered modern medicine through the long effort to explain why thalidomide caused birth differences when used in pregnancy in the late 1950s and early 1960s. In recent decades, awareness of this gene’s role has grown as researchers linked cereblon, the protein made from the CRBN gene, to thalidomide and related medicines. A major turning point came in 2010, when studies identified cereblon as a key binding partner for thalidomide. From these first observations, research expanded steadily. Scientists then showed that this discovery could help explain both harmful effects in fetal development and the drug’s value in blood cancer treatment. Today, CRBN is widely recognized in research on thalidomide-like medicines and targeted cancer therapy.